Back to Show
PBS NewsHour
Why aren't generic drugs coming to market sooner?
The FTC's recent $1.2 billion settlement over the drug Provigil has brought so-called "pay for delay" deals for generic drugs back into the spotlight. Opponents say these deals delay generic medications to market, costing consumers billions. But drug companies say that the deals help get generics to market by avoiding lengthy patent litigation. NewsHour's Megan Thompson reports.
Support Provided By
Season
57:46
March 27, 2024 - PBS NewsHour full episode
57:46
A Baltimore bridge collapses after being struck by a container ship.
57:46
The rift between the U.S. and Israel widens due to a United Nations resolution demanding a cease-fire in Gaza.
26:44
With the Supreme Court set to hear arguments Tuesday in a case about mifepristone, a look at the ways the executive branch can shape reproductive rights and abortion access in post-Roe America.
26:45
The deadliest massacre in Russia in decades leaves the country on edge, just days after President Putin was re-elected.
57:46
Congress works to avoid a partial government shutdown, but could it cost House Speaker Johnson his gavel?
57:46
March 21, 2024 - PBS NewsHour full episode
57:46
March 20, 2024 - PBS NewsHour full episode
57:46
An immigration ruling from the Supreme Court means Texas police can now arrest and deport migrants.
57:46
Russian President Vladimir Putin extends his reign after securing a landslide but rigged seventh term.
26:45
With hundreds of thousands of Americans relying on Catholic hospitals, why some people are facing barriers to reproductive health care.
26:44
Examine the safety and reliability of helicopters after a string of fatal crashes.